Squarepoint Ops LLC Argenx Se Transaction History

Squarepoint Ops LLC

$93.7 Billion
Q2 2025

A detailed history of Squarepoint Ops LLC transactions in Argenx Se stock. As of the latest transaction made, Squarepoint Ops LLC holds 31,296 shares of ARGX stock, worth $25 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

31,296

Previous 30,421 2.88%

Holding current value

$25 Million

Previous $18 Million 4.19%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 27, 2025	BUY	$532.27 - $656.65 $465,736 - $574,568	875 Added 2.88%	31,296 $17.3 Million
Q2 2025 Aug 14, 2025	BUY	$532.27 - $656.65 $465,736 - $574,568	875 Added 2.88%	31,296 $17.3 Million
Q1 2025 Aug 27, 2025	SELL	$571.0 - $671.75 $499,625 - $587,781	-875 Reduced 2.8%	30,421 $18 Million
Q1 2025 May 15, 2025	BUY	$571.0 - $671.75 $4.43 Million - $5.21 Million	7,757 Added 34.23%	30,421 $18 Million
Q4 2024 Feb 14, 2025	BUY	$520.52 - $638.33 $2.22 Million - $2.72 Million	4,264 Added 23.17%	22,664 $13.9 Million
Q3 2024 Nov 14, 2024	SELL	$434.22 - $551.9 $10 Million - $12.7 Million	-23,092 Reduced 55.65%	18,400 $9.98 Million
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $4.85 Million - $6.15 Million	13,618 Added 48.86%	41,492 $17.8 Million
Q1 2024 May 15, 2024	BUY	$356.95 - $413.29 $3.38 Million - $3.92 Million	9,474 Added 51.49%	27,874 $11 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $5.93 Million - $8.85 Million	17,492 Added 1926.43%	18,400 $7 Million
Q2 2023 Aug 14, 2023	SELL	$360.14 - $422.58 $1.11 Million - $1.3 Million	-3,082 Reduced 77.24%	908 $353,000
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $1.33 Million - $1.61 Million	3,990 New	3,990 $1.49 Million
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $3.98 Million - $4.59 Million	11,589 Added 638.16%	13,405 $4.73 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $489,557 - $688,046	1,816 New	1,816 $688,000
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $1.19 Million - $1.64 Million	-4,667 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $211,079 - $273,951	776 Added 19.94%	4,667 $1.63 Million
Q3 2021 Nov 15, 2021	BUY	$295.0 - $350.58 $1.15 Million - $1.36 Million	3,891 New	3,891 $1.18 Million
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $467,168 - $581,294	-1,817 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$268.3 - $380.31 $487,501 - $691,023	1,817 New	1,817 $500,000
Q2 2019 Aug 14, 2019	SELL	$115.0 - $141.58 $202,170 - $248,897	-1,758 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$98.85 - $134.59 $173,778 - $236,609	1,758 New	1,758 $219,000
Q4 2018 Feb 14, 2019	SELL	$63.81 - $109.82 $240,882 - $414,570	-3,775 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $285,012 - $364,778	3,775 New	3,775 $286,000

Others Institutions Holding ARGX

# of Institutions

492

Shares Held

28.2M

Call Options Held

370K

Put Options Held

211K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $44.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Argenx Se Transaction History